Summit
FT Global Pharma and Biotech Summit
A high level executive summit gathering global biopharma leaders, investors, and policymakers to debate commercial and therapeutic strategies.
- When
- November, Early November
- Where
- London, UKView on Google Maps
- Format
- Hybrid
- Organiser
- Financial Times
- Region
- Europe
- Scale
- About 500 attendees
- Founded
- 2010
The Signal
Organized by the Financial Times, this summit brings together C-suite executives from the global pharmaceutical and biotechnology industries. Discussions center on geopolitical challenges, drug pricing, dealmaking, and scientific breakthroughs. For life science investors, it provides high level strategic signals on market direction.
What to expect
- Drug pricing policies and market access
- Artificial intelligence in drug discovery
- Pharma dealmaking and therapeutic focus areas
Who is in the room
Pharmaceutical executives, biotech founders, healthcare venture capitalists, and health policy officials.
Background
The summit has long been a key calendar event for life science leaders in Europe. It has increasingly integrated computational biology and healthtech partnership topics into its core agenda.
Related events
Running this event, or spotted something out of date?